Research Site — San Francisco, California

Public research footprint of Research Site, compiled from the ClinicalTrials.gov public registry.

292

Registered studies

122

Active

Recruiting now

127

Completed

Stopped or withdrawn

Most-studied conditions

Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer · HR Low-Positive/HER2-Negative Breast Neoplasms · Advanced Non-Small Cell Lung Cancer · Diffuse Large B-Cell Lymphoma

Recently updated registry entries

NCT04613596 — Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase… (Recruiting)
NCT06081894 — A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults… (Active Not Recruiting)
NCT06330064 — A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Research Site?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.